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Conclusion: These initial results indicate that aden-
oviruses are a signiﬁcant cause of respiratory disease among
children under ﬁve. Specimen collection is on-going, and
future results will further clarify the epidemiology of ade-
novirus disease in Kenya. Subtyping of the isolates will be
determined by PCR and reported.
doi:10.1016/j.ijid.2008.05.813
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Background: Photodynamic therapy utilizes a photosen-
sitizer, which upon excitation, emits energy that could be
transduced by surrounding molecular oxygen to produce rad-
ical oxygen species. Interaction between the singlet oxygen
species and viruses may have a virucidal effect. In this study,
the potential of using a novel photodynamic system to inac-
tivate enveloped virus was investigated.
Methods: The photosensitizer used was zinc-
phthalocyanine (ZnPC), which was absorbed onto a
novel two-photon nanotransducer (NaYF4) that is activated
by near infrared light (NIR). Dengue 2 virus was mixed with
different concentrations of nanoparticles and exposed to
a NIR light source at varying distances (5 cm and 10 cm)
and durations (5minutes and 10minutes). The amount
of surviving viruses was analyzed using plaque assay and
compared with untreated virus samples. Further photo-
inactivation study is being done on dengue 2 virus-infected
HepG2 cells using nanoparticles that were conjugated with
antibodies speciﬁc for the dengue virus envelope protein.
The infected cells were incubated with the antibody-
conjugated nanoparticles (4 to 110g/mL) and subjected
to NIR illumination (10 cm for 5minutes).
Results: The level of virus inactivation increased with
higher nanoparticle concentrations and at shorter distance
and longer illumination from the NIR source. At all con-
ditions, virus inactivation was complete when 2.2mg/mL
nanoparticles were used and at 44g/mL, virus titer was
reduced by more than 50%. Conjugation with antibody may
enhance the localization of the photo-inactivation site to
targeted viruses or to virus-infected cells only, as shown
by electron and laser scanning confocal microscopy. In
addition, cell viability (MTT) assay showed that the photo-
bleaching effect by NIR light on HepG2 cells was only
minimal.
Conclusion: Given its effectiveness in eradicating virus
activity and its non-cytotoxic effect on cells, photodynamic
therapy using NIR light could be a feasible novel technology
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Background: Since 2002, increasing incidence of aman-
tadine resistance has been detected worldwide. In a minor
extent, emergence of oseltamivir-resistant strains has been
identiﬁed during 2007/2008 winter season. This study aims
to contribute to global surveillance on antiviral resistance
and to risk assessment of drug use with continuous liber-
ation of national data. Its main objective is to evaluate
inﬂuenza virus susceptibility to oseltamivir and amantadine
during 2004/2005—2007/2008, in Portugal.
Methods: Susceptibility to oseltamivir was eval-
uated by ﬂuorescence assay in 233 strains from
2004/2005—2007/2008. NA and HA1 gene sequencing
was performed in statistical outliers and in 30% of sus-
ceptible strains, identiﬁed by ﬂuorescence. Resistance to
amantadine was evaluated by pyrosequencing in 128 strains
from 2004/2005—2006/2007.
Results: All 89 A(H3N2) and 94 B inﬂuenza strains
tested shown to be oseltamivir-susceptible. Of the 50
A(H1N1) strains tested, 3 of the 14 from 2007/2008
were drug-resistant by exhibiting ﬂuorescence-IC50 values
approximately 400 times higher than the median value and
mutation H274Y in NA sequence. Susceptibility to aman-
tadine was detected in all 23 A(H1N1) strains tested.
Resistance was found, by identiﬁcation of mutation S31N in
M2 sequence, in 24 of the 105 A(H3N2) strains tested: in the
single strain from 2005/2006 and in 23 of the 35 strains from
2006/2007.
Discussion: The origin of oseltamivir-resistant A(H1N1)
strains in Portugal (2007/2008), and concurrently in other
European countries, remains unclear. Their persistence
through inﬂuenza seasons and their effect in viral evolution
could become clearer with subsequent and continuous data
analysis. Conversely, emergence of amantadine resistance
in Portugal, identiﬁed in 2005/2006 and persistent through
2006/2007, probably derived from global spread of A(H3N2)
virus bearing mutation S31N. These preliminary ﬁndings can
presently contribute to monitor international dispersion of
resistant viruses. Continuous and timely input of national
data onto global surveillance constitutes the basis for risk
assessment on antiviral drug use.
doi:10.1016/j.ijid.2008.05.815
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Background: Recently, there has been a marked resur-
gence of Dengue Fever (DF) in Singapore. More adults with
chronic diseases including patients on antithrombotic ther-
